Frontlight ResearchEarly access
Trial site
INSTYTUT GENETYKI I IMMUNOLOGII GENIM Sp z o o
- 5running trials
- 3closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Lung cancer8 trials
- Phase
- Phase 37 trials
- Phase 1/21 trial
- Status
- Completed3 trials
- Active, not recruiting2 trials
- Recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Pfizer2 trials
- Bristol-Myers Squibb1 trial
- Hoffmann-La Roche1 trial
- ImmunityBio, Inc.1 trial
- Janssen Research & Development, LLC1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Active, not recruiting
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
Closed trials
Active, not recruiting
Active, not recruiting
Active, not recruiting
Site data: ClinicalTrials.govUpdated 19 Nov 2026